Empirical study on the effect of pandemic crises on the pricing of pharmaceutical and biotech IPOs
Lista, Luigi (A.A. 2020/2021) Empirical study on the effect of pandemic crises on the pricing of pharmaceutical and biotech IPOs. Tesi di Laurea in Advanced corporate finance, Luiss Guido Carli, relatore Raffaele Oriani, pp. 76. [Master's Degree Thesis]
Full text for this thesis not available from the repository.
Abstract/Index
Pricing in IPOs and the phenomenon of underpricing. IPOs: the importance of pricing for the success of an operation and its mechanisms. The valuation of the company shares and the pricing mechanism of IPOs. IPOs and underpricing: analysis of the different theoretical strands that analyze underpriced IPOs. Underpricing calculation and determination: empirical considerations. Covid-19, health care crisis and IPO performance in the biotechnology and pharmaceutical sector. Analysis of the pre-covid biotech and pharmaceutical sectors. The strategic importance of the biotech new firms for the pharmaceutical industry. Biotech sector reaction to the spread of new Covid-19 virus. Analysis of the trend of IPOs in the biotech & pharma sector in 2019-2020. IPO underpricing & Covid-19 crisis: an empirical analysis.
References
Bibliografia: pp. 59-62.
| Thesis Type: | Master's Degree Thesis |
|---|---|
| Institution: | Luiss Guido Carli |
| Degree Program: | Master's Degree Programs > Master's Degree program in Corporate Finance, English language (LM-77) |
| Chair: | Advanced corporate finance |
| Thesis Supervisor: | Oriani, Raffaele |
| Thesis Co-Supervisor: | Bruno, Riccardo |
| Academic Year: | 2020/2021 |
| Session: | Summer |
| Deposited by: | Alessandro Perfetti |
| Date Deposited: | 18 Jan 2022 17:33 |
| Last Modified: | 18 Jan 2022 17:33 |
| URI: | https://tesi.luiss.it/id/eprint/31163 |
Downloads
Downloads per month over past year
Repository Staff Only
 |
View Item |
